Tadahisa Sugiura1, Shuhei Tara1, Hidetaka Nakayama2, Hirotsugu Kurobe1, Tai Yi1, Yong-Ung Lee1, Avione Y Lee1, Christopher K Breuer1, Toshiharu Shinoka3. 1. Tissue Engineering Program and Surgical Research, Nationwide Children's Hospital, Columbus, Ohio. 2. QOL Research Center Laboratory, Gunze Limited, Ayabe-shi, Kyoto, Japan. 3. Tissue Engineering Program and Surgical Research, Nationwide Children's Hospital, Columbus, Ohio; Department of Cardiothoracic Surgery, Nationwide Children's Hospital, Columbus, Ohio. Electronic address: toshiharu.shinoka@nationwidechildrens.org.
Abstract
BACKGROUND: Current commercialized small-diameter arterial grafts have not shown clinical effectiveness due to their poor patency rates. The present study evaluated the feasibility of an arterial bioresorbable vascular graft, which has a porous sponge-type scaffold, as a small-diameter arterial conduit. METHODS: The grafts were constructed by a 50:50 poly (1-lactic-co-ε-caprolactone) copolymer (PLCL) scaffold reinforced by a poly (1-lactic acid) (PLA) nanofiber. The pore size of the PLCL scaffold was adjusted to a small size (12.8 ± 1.85 μm) or a large size (28.5 ± 5.25 μm). We compared the difference in cellular infiltration, followed by tissue remodeling, between the groups. The grafts were implanted in 8- to 10-week-old female mice (n = 15 in each group) as infrarenal aortic interposition conduits. Animals were monitored for 8 weeks and euthanized to evaluate neotissue formation. RESULTS: No aneurysmal change or graft rupture was observed in either group. Histologic assessment demonstrated favorable cell infiltration into scaffolds, neointimal formation with endothelialization, smooth muscle cell proliferation, and elastin deposition in both groups. No significant difference was observed between the groups. Immunohistochemical characterization with anti-F4/80 antibody demonstrated that macrophage infiltration into the grafts occurred in both groups. Staining for M1 and M2, which are the two major macrophage phenotypes, showed no significant difference between groups. CONCLUSIONS: Our novel bioresorbable vascular grafts showed well-organized neointimal formation in the high-pressure arterial circulation environment. The large-pore scaffold did not improve cellular infiltration and neotissue formation compared with the small-pore scaffold.
BACKGROUND: Current commercialized small-diameter arterial grafts have not shown clinical effectiveness due to their poor patency rates. The present study evaluated the feasibility of an arterial bioresorbable vascular graft, which has a porous sponge-type scaffold, as a small-diameter arterial conduit. METHODS: The grafts were constructed by a 50:50 poly (1-lactic-co-ε-caprolactone) copolymer (PLCL) scaffold reinforced by a poly (1-lactic acid) (PLA) nanofiber. The pore size of the PLCL scaffold was adjusted to a small size (12.8 ± 1.85 μm) or a large size (28.5 ± 5.25 μm). We compared the difference in cellular infiltration, followed by tissue remodeling, between the groups. The grafts were implanted in 8- to 10-week-old female mice (n = 15 in each group) as infrarenal aortic interposition conduits. Animals were monitored for 8 weeks and euthanized to evaluate neotissue formation. RESULTS: No aneurysmal change or graft rupture was observed in either group. Histologic assessment demonstrated favorable cell infiltration into scaffolds, neointimal formation with endothelialization, smooth muscle cell proliferation, and elastin deposition in both groups. No significant difference was observed between the groups. Immunohistochemical characterization with anti-F4/80 antibody demonstrated that macrophage infiltration into the grafts occurred in both groups. Staining for M1 and M2, which are the two major macrophage phenotypes, showed no significant difference between groups. CONCLUSIONS: Our novel bioresorbable vascular grafts showed well-organized neointimal formation in the high-pressure arterial circulation environment. The large-pore scaffold did not improve cellular infiltration and neotissue formation compared with the small-pore scaffold.
Authors: Kristine C Rustad; Michael Sorkin; Benjamin Levi; Michael T Longaker; Geoffrey C Gurtner Journal: Organogenesis Date: 2010 Jul-Sep Impact factor: 2.500
Authors: Tamar L Mirensky; Gregory N Nelson; Matthew P Brennan; Jason D Roh; Narutoshi Hibino; Tai Yi; Toshiharu Shinoka; Christopher K Breuer Journal: J Pediatr Surg Date: 2009-06 Impact factor: 2.545
Authors: Kevin A Rocco; Mark W Maxfield; Cameron A Best; Ethan W Dean; Christopher K Breuer Journal: Tissue Eng Part B Rev Date: 2014-06-18 Impact factor: 6.389
Authors: Jason D Roh; Rajendra Sawh-Martinez; Matthew P Brennan; Steven M Jay; Lesley Devine; Deepak A Rao; Tai Yi; Tamar L Mirensky; Ani Nalbandian; Brooks Udelsman; Narutoshi Hibino; Toshiharu Shinoka; W Mark Saltzman; Edward Snyder; Themis R Kyriakides; Jordan S Pober; Christopher K Breuer Journal: Proc Natl Acad Sci U S A Date: 2010-03-05 Impact factor: 11.205
Authors: Cansu Karakaya; Jordy G M van Asten; Tommaso Ristori; Cecilia M Sahlgren; Sandra Loerakker Journal: Biomech Model Mechanobiol Date: 2021-10-06
Authors: I S Zakharova; M K Zhiven'; Sh B Saaya; A I Shevchenko; A M Smirnova; A Strunov; A A Karpenko; E A Pokushalov; L N Ivanova; P I Makarevich; Y V Parfyonova; E Aboian; S M Zakian Journal: J Transl Med Date: 2017-03-03 Impact factor: 5.531
Authors: Renee Duijvelshoff; Nicole C A van Engeland; Karen M R Gabriels; Serge H M Söntjens; Anthal I P M Smits; Patricia Y W Dankers; Carlijn V C Bouten Journal: Bioengineering (Basel) Date: 2018-08-06